A prospective study of Mohs’ micrographic surgery in two English centres

Julian, C G; Bowers, P.W.

doi:10.1046/j.1365-2133.1997.d01-1227.x

Cited by 27 publications

(23 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The use of MMS over the 11‐year study period resulted in a 5‐year recurrence rate of 4.6%. This rate is below the rates of other therapeutic modalities and similar to those found in other European and North American medical centers, which have reported 5‐year recurrence rates of 1‐6.7% using the same surgical techniques and MMS indications …”

Section: Discussionsupporting

confidence: 83%

Macrophage subtypes in recurrent nodular basal cell carcinoma after Mohs micrographic surgery

et al. 2017

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 83%

Macrophage subtypes in recurrent nodular basal cell carcinoma after Mohs micrographic surgery

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Other European centres with similar indications for MMS have reported 5-year recurrence rates of 1.7-3.2% for primary BCCs and 4.8-6.7% for recurrent BCCs using the same MMS technique and similar indications (10,11). Variants of micrographie surgery that also allow for complete examination of all tissue margins have shown comparable 5-year recurrence rates: 3.3% for primary BCCs and 7.3% for recurrent BCCs (12).…”

Section: Discussionmentioning

confidence: 80%

5-year Recurrence Rates of Mohs Micrographic Surgery for Aggressive and Recurrent Facial Basal Cell Carcinoma

Paoli¹,

Daryoni²,

Wennberg³

et al. 2011

Acta Derm Venerol

View full text Add to dashboard Cite

Mohs micrographic surgery allows for complete microscopic examination of the surgical margin when treating aggressive and recurrent facial basal cell carcinomas. This leads to the highest cure rates and maximal preservation of healthy tissue. The 5-year recurrence rates of 587 aggressive and/or recurrent facial basal cell carcinomas treated during 1993 to 2003 at our centre were studied retrospectively. The resulting 5-year recurrence rates using Kaplan-Meier survival analysis were 2.1% for primary (previously untreated) tumours, 5.2% for recurrent basal cell carcinomas and 3.3% overall. In total, 87.9% of the tumours required at least two stages of Mohs micrographic surgery. The surgical defect's size after complete excision was, on average, approximately twice the size of the defect after excision of the clinically visible tumour with a 2-3 mm margin. Mohs micro-graphic surgery is underused in Scandinavia despite being the treatment of choice for aggressive and recurrent facial basal cell carcinomas.

show abstract

“…The final total of 18 patient series [28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43] included reports on the treatment of 9930 primary BCCs ( Table 2). Some patients were observed for more than 5 years; the exact figures could not be calculated because several studies mentioned only the recurrence rates without the absolute number of patients with BCC observed for more than 5 years.…”

Section: Discussionmentioning

confidence: 99%